I most certainly don’t want to upset the apple carts but (as a long term holder & "hoper" and at the risk of getting a kicking)... I think announcing these figures to the market was not a good move. Apart from being “unsigned” by the CEO, the numbers are inaccurate and may give some prospective & existing shareholders a distorted picture.
As usual, the narrative is typically upbeat & positive sounding - which is obviously what we want to see, but to me, and I am very happy to be corrected on this, there is a lack of narrative explaining why most of the operating cost numbers don’t add up, as follows:·There appears to be a $70 discrepancy in the R&D Costs from Q12020
·There appears to be a $743 hole in the Production Manufacturing Costs from Q12020
·There appears to be a $56 discrepancy in the Advertising Costs from Q12020
·There appears to be a $17 discrepancy in the Advertising Costs from Q12020
·There appears to be a $887 hole in the Admin & Corporate Costs from Q12020
Whether they have just announced a draft copy, or they haven’t checked the numbers I don’t know – but to me, this is no excuse and is not good enough. Here’s my other thoughts…·Admin Costs – 61% increase compared to Q22019
·Net cash position is worse than Q22019 (& that included the the Ikon debacle payment) as well as the issuance of more share capital last year
·Overall, there was an average 57% increase of actual cash expenditure from what was estimated in Q12020 (including a 217% over estimation in the Admin Costs alone)
Overall, I was underwhelmed and I am hoping like hell the above was just an unfortunate error – or that I am looking at the wrong 4C!
- Forums
- ASX - By Stock
- Ann: Appendix 4C and Notes to Appendix 4C
I most certainly don’t want to upset the apple carts but (as a...
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online